Cases & Deals

SymBiosis participates in €18 million Series B financing round of MaaT Pharma

Clients SymBiosis, LLC

Jones Day advised SymBiosis LLC, as lead investor, in connection with the €18 million Series B round of financing of MaaT Pharma, a French clinical-stage company developing microbiome-based biotherapeutics.